Shares of Braskem cratered 16.7% to $4.25 as Brazil's largest petrochemical company formally filed for extrajudicial reorganization — an out-of-court debt restructuring — covering roughly US$10.9 billion in unsecured financial obligations. The move, while anticipated, crystallizes investor fears that equity holders face severe dilution or total loss in the months ahead.
The Filing Was a Race Against the Clock. The filing came as a 60-day protective court order expired on August 24, shielding Braskem from creditor enforcement actions while it mediated terms.
Had no deal been in place by the deadline, the company risked being pushed into a formal, court-run restructuring — the outcome it had been trying to avoid all year.
Braskem secured support from unsecured creditors representing 39.6% of covered claims — enough to file but well short of the threshold needed for final approval.
The company now has 90 days to reach the minimum creditor percentage required for an approved plan.
The Balance Sheet Is Already Underwater. Auditors flagged that negative equity of R$13,087 million and current liabilities exceeding current assets by R$8,701 million cast significant doubt on Braskem's ability to continue as a going concern.
Consolidated borrowings topped R$49 billion, while cash plunged to R$3.9 billion from R$10.5 billion.
Analysts warn equity value is likely to be destroyed by debt-for-equity swaps — where lenders trade what they're owed for ownership shares — or deep dilution.
Braskem Is Fighting on Two Fronts at Once. Its Mexican subsidiary Braskem Idesa separately filed a prepackaged Chapter 11 on August 18 to slash US$2.5 billion in senior debt to roughly US$1.6 billion.
Braskem will inject US$476 million into that unit — cash leaving the parent at its weakest moment.
Petrobras Holds a Critical Lifeline. Braskem disclosed it is in advanced talks with controlling shareholder Petrobras for a R$2.35 billion (US$456 million) commercial credit line to finance feedstock purchases, with a final maturity of December 31, 2026.
The line is structured as commercial credit — not an equity rescue — and is conditional on Petrobras board approval and the continuation of the restructuring process.
The most recent analyst rating on BAK is a Sell with a $3.00 price target — implying another 29% downside from here. At $4.25, the stock is a distressed bet that creditors will leave something for shareholders. History says they usually don't.